Komboglyze
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Komboglyze, covering 2025-05-23 to 2025-05-23. Get the full timeline:
Most recent: EMA Authorised: Komboglyze (metformin hydrochloride;saxagliptin hydrochloride) — AstraZeneca AB